These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21862583)

  • 1. Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-kappaB ligand-neutralizing antibody: evidence for bone anabolic effect of parathyroid hormone in mice with few osteoclasts.
    Furuya Y; Mori K; Ninomiya T; Tomimori Y; Tanaka S; Takahashi N; Udagawa N; Uchida K; Yasuda H
    J Biol Chem; 2011 Oct; 286(42):37023-31. PubMed ID: 21862583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
    Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
    J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of bone formation in cortical bone of mice treated with a receptor activator of nuclear factor-κB ligand (RANKL)-binding peptide that possesses osteoclastogenesis inhibitory activity.
    Furuya Y; Inagaki A; Khan M; Mori K; Penninger JM; Nakamura M; Udagawa N; Aoki K; Ohya K; Uchida K; Yasuda H
    J Biol Chem; 2013 Feb; 288(8):5562-71. PubMed ID: 23319583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.
    Sankar U; Patel K; Rosol TJ; Ostrowski MC
    J Bone Miner Res; 2004 Aug; 19(8):1339-48. PubMed ID: 15231022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone 1 (1-34) acts on the scales and involves calcium metabolism in goldfish.
    Suzuki N; Danks JA; Maruyama Y; Ikegame M; Sasayama Y; Hattori A; Nakamura M; Tabata MJ; Yamamoto T; Furuya R; Saijoh K; Mishima H; Srivastav AK; Furusawa Y; Kondo T; Tabuchi Y; Takasaki I; Chowdhury VS; Hayakawa K; Martin TJ
    Bone; 2011 May; 48(5):1186-93. PubMed ID: 21334472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of ferric ion on the differentiation of osteoclast and bone resorption].
    Jia P; He YF; Gao C; Du HB; Hu ZY; Feng XQ; Li BY; Zhang ZL; Xu YJ; Lin H
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2214-8. PubMed ID: 23158430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass.
    Mun SH; Won HY; Hernandez P; Aguila HL; Lee SK
    J Bone Miner Res; 2013 Apr; 28(4):948-59. PubMed ID: 23044992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockout of TRPV6 causes osteopenia in mice by increasing osteoclastic differentiation and activity.
    Chen F; Ni B; Yang YO; Ye T; Chen A
    Cell Physiol Biochem; 2014; 33(3):796-809. PubMed ID: 24686448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-magnitude high-frequency vibration inhibits RANKL-induced osteoclast differentiation of RAW264.7 cells.
    Wu SH; Zhong ZM; Chen JT
    Int J Med Sci; 2012; 9(9):801-7. PubMed ID: 23136544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directly.
    Yu M; Moreno JL; Stains JP; Keegan AD
    J Biol Chem; 2009 Nov; 284(47):32968-79. PubMed ID: 19801646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A(2A) receptor ligation inhibits osteoclast formation.
    Mediero A; Kara FM; Wilder T; Cronstein BN
    Am J Pathol; 2012 Feb; 180(2):775-86. PubMed ID: 22138579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
    Harada S; Mizoguchi T; Kobayashi Y; Nakamichi Y; Takeda S; Sakai S; Takahashi F; Saito H; Yasuda H; Udagawa N; Suda T; Takahashi N
    J Bone Miner Res; 2012 Feb; 27(2):461-73. PubMed ID: 22052469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
    Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
    Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in mice.
    Williams DW; Lee C; Kim T; Yagita H; Wu H; Park S; Yang P; Liu H; Shi S; Shin KH; Kang MK; Park NH; Kim RH
    Am J Pathol; 2014 Nov; 184(11):3084-93. PubMed ID: 25173134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
    Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA
    J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
    Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
    Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoclastogenesis during mouse tooth germ development is mediated by receptor activator of NFKappa-B ligand (RANKL).
    Suzuki T; Suda N; Ohyama K
    J Bone Miner Metab; 2004; 22(3):185-91. PubMed ID: 15108059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble RANKL induces high bone turnover and decreases bone volume, density, and strength in mice.
    Lloyd SA; Yuan YY; Kostenuik PJ; Ominsky MS; Lau AG; Morony S; Stolina M; Asuncion FJ; Bateman TA
    Calcif Tissue Int; 2008 May; 82(5):361-72. PubMed ID: 18465074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.